Medicare Part B Home Infusion Services Temporary Transitional Payment Act

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

Medicare physician payment; new/alternative payment models; Medicare coverage, including coverage policies pertaining to transcatheter aortic valve replacement, transcathether mitral valve repair, and ambulatory blood pressure monitoring; Medicare hospital payment; access to Medicare claims data; Ways & Means Committee hospital payment project; physician and hospital quality; electronic health record incentive program; clinical data registries; health care quality; medical imaging and prior authorization, including HR 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018; the Stark Law and the in-office ancillary services exception, including HR 4206/S 2051, the Medicare Care Coordination Improvement Act; Promoting Integrity in Medicare Act, HR 2066; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; HR 1155/S 1361, a bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs; S 46, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017; HR 3325/S 428, The Advancing Care for Exceptional Kids Act of 2017 (or ACE Kids Act), a bill to allow a state, at its option, to elect to provide medical assistance for items and services furnished to eligible children with medically complex conditions enrolled in a Medicaid Children's Care Coordination (MCCC) program; Senate Finance Committee chronic care project; graduate medical education policy including HR 2267/S 1301, Resident Physician Shortage Reduction Act of 2017; end of life care, including HR 2797/S 1334, the Patient Choice and Quality Care Act of 2017; Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) implementation; oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; physician-owned hospital policy, including HR 1156/S 1133, the Patient Access to High Quality Care Act of 2017; Medicaid coverage and eligibility, including HR 829, Prioritizing the Most Vulnerable Over Lottery Winners Act of 2017, HR 181, Close Annuity Loopholes in Medicaid Act, and HR 705, Verify Eligibility Coverage Act; HR 3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; Affordable Care Act repeal/replace/reform efforts; HR 3767 and S 989, the Ensuring Childrens Access to Specialty Care Act of 2017; HR 3635, the Local Coverage Determination Clarification Act of 2017; Ways and Means Committee Medicare extenders policy/legislation.

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues.

Client expense: $140,000 · Firm income: Not reported

Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of 21st Century Cures Act (P.L.114-255). S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. Implementation of H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act.

Client expense: $320,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Medicare physician payment; new/alternative payment models; Medicare coverage, including coverage policies pertaining to implantable cardioverter-defibrillators and transcatheter aortic valve replacement; Medicare hospital payment; access to Medicare claims data; Ways & Means Committee hospital payment project; physician and hospital quality; electronic health record incentive program; clinical data registries; health care quality; medical imaging and prior authorization, including HR 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018; the Stark Law and the in-office ancillary services exception, including HR 4206/S 2051, the Medicare Care Coordination Improvement Act; Promoting Integrity in Medicare Act, HR 2066; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; HR 1155/S 1361, a bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs; S 46, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017; HR 3325/S 428, The Advancing Care for Exceptional Kids Act of 2017 (or ACE Kids Act), a bill to allow a state, at its option, to elect to provide medical assistance for items and services furnished to eligible children with medically complex conditions enrolled in a Medicaid Children's Care Coordination (MCCC) program; Senate Finance Committee chronic care project; graduate medical education policy including HR 2267/S 1301, Resident Physician Shortage Reduction Act of 2017; end of life care, including HR 2797/S 1334, the Patient Choice and Quality Care Act of 2017; Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) implementation; oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; physician-owned hospital policy, including HR 1156/S 1133, the Patient Access to High Quality Care Act of 2017; Medicaid coverage and eligibility, including HR 829, Prioritizing the Most Vulnerable Over Lottery Winners Act of 2017, HR 181, Close Annuity Loopholes in Medicaid Act, and HR 705, Verify Eligibility Coverage Act; HR 3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; Affordable Care Act repeal/replace/reform efforts; HR 3767 and S 989, the Ensuring Childrens Access to Specialty Care Act of 2017; HR 3635, the Local Coverage Determination Clarification Act of 2017; Ways and Means Committee Medicare extenders policy/legislation.

Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of 21st Century Cures Act (P.L.114-255). S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. Implementation of H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act.

Client expense: $420,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs.

Client expense: $160,000 · Firm income: Not reported

Medicare physician payment; new/alternative payment models; Medicare coverage, including coverage policies pertaining to implantable cardioverter-defibrillators and transcatheter aortic valve replacement; Medicare hospital payment; access to Medicare claims data; Ways & Means Committee hospital payment project; physician and hospital quality; electronic health record incentive program; clinical data registries; health care quality; medical imaging and prior authorization, including HR 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018; the Stark Law and the in-office ancillary services exception, including HR 4206/S 2051, the Medicare Care Coordination Improvement Act; Promoting Integrity in Medicare Act, HR 2066; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; HR 1155/S 1361, a bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs; S 46, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017; HR 3325/S 428, The Advancing Care for Exceptional Kids Act of 2017 (or ACE Kids Act), a bill to allow a state, at its option, to elect to provide medical assistance for items and services furnished to eligible children with medically complex conditions enrolled in a Medicaid Children's Care Coordination (MCCC) program; Senate Finance Committee chronic care project; graduate medical education policy including HR 2267/S 1301, Resident Physician Shortage Reduction Act of 2017; end of life care, including HR 2797/S 1334, the Patient Choice and Quality Care Act of 2017; Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) implementation; oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; physician-owned hospital policy, including HR 1156/S 1133, the Patient Access to High Quality Care Act of 2017; Medicaid coverage and eligibility, including HR 829, Prioritizing the Most Vulnerable Over Lottery Winners Act of 2017, HR 181, Close Annuity Loopholes in Medicaid Act, and HR 705, Verify Eligibility Coverage Act; HR 3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; Affordable Care Act repeal/replace/reform efforts; HR 3767 and S 989, the Ensuring Childrens Access to Specialty Care Act of 2017; HR 3635, the Local Coverage Determination Clarification Act of 2017; Ways and Means Committee Medicare extenders policy/legislation.

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project.

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

114th Congress HR 605/S. 275 - Reintroduction of The Medicare Home Infusion Site of Care Act HR 3178, S. 1738, HR 3163, HR 1892 - lobbied House and Senate, CMS on proper implementation of the legislation. H.R.4724 - Medicare IVIG Access Enhancement Act, technical assistance

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of 21st Century Cures Act (P.L.114-255). S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.3120, An original bill to amend titles XVIII and XIX of the Social Security Act to help end addictions and lessen substance abuse disorders, and for other purposes. H.R.6, SUPPORT for Patients and Communities Act.

Client expense: $410,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Patient infusion therapy and reimbursement/policy issues related to non-opioid acute pain management. S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.3120, An original bill to amend titles XVIII and XIX of the Social Security Act to help end addictions and lessen substance abuse disorders, and for other purposes. H.R.6, SUPPORT for Patients and Communities Act.

Client expense: $410,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Issues related to prescription drug abuse, Medicare Part D, and Medicare payment for home infusion. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 S. 2460/H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S. 1738/H.R. 3163, The Medicare Home Infusion Therapy Act of 2017 H.R. 3178, The Medicare Part B Improvement Act of 2017 S. 2553, The Know the Lowest Price Act of 2018 H.R. 4841, The Standardizing Electronic Prior Authorization for Safe Prescribing Act

Client expense: $1,803,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.

Client expense: $510,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; issues related to patient infusion therapy. H.R.195, Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes (P.L.115-120); H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123); issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Medical device technology related to the opioid epidemic.

Client expense: $510,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Medicare physician payment; new/alternative payment models; Medicare coverage; Medicare hospital payment; access to Medicare claims data; Ways & Means Committee hospital payment project; physician and hospital quality; electronic health record incentive program; clinical data registries; health care quality; medical imaging and prior authorization, including HR 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018; the Stark Law and the in-office ancillary services exception, including HR 4206/S 2051, the Medicare Care Coordination Improvement Act; Promoting Integrity in Medicare Act, HR 2066; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; HR 1155/S 1361, a bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs; S 46, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017; HR 3325/S 428, The Advancing Care for Exceptional Kids Act of 2017 (or ACE Kids Act), a bill to allow a state, at its option, to elect to provide medical assistance for items and services furnished to eligible children with medically complex conditions enrolled in a Medicaid Children's Care Coordination (MCCC) program; Senate Finance Committee chronic care project; graduate medical education policy including HR 2267/S 1301, Resident Physician Shortage Reduction Act of 2017; end of life care, including HR 2797/S 1334, the Patient Choice and Quality Care Act of 2017; Children's Health Insurance Program (CHIP) extension, including HR 3922, the CHAMPIONING HEALTHY KIDS Act; Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) implementation; oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; repeal of the Independent Payment Advisory Board (IPAB), including S 251, the Protecting Medicare from Executive Action Act, S 260, the Protecting Seniors' Access to Medicare Act, SJ Res 16, SJ Res 17, and HR Res 51, joint resolutions approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Payment Advisory Board, and HR 849, a bill to repeal the IPAB; physician-owned hospital policy, including HR 1156/S 1133, the Patient Access to High Quality Care Act of 2017; Medicaid coverage and eligibility, including HR 829, Prioritizing the Most Vulnerable Over Lottery Winners Act of 2017, HR 181, Close Annuity Loopholes in Medicaid Act, and HR 705, Verify Eligibility Coverage Act; HR 3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; Affordable Care Act repeal/replace/reform efforts, including the American Health Care Act, the Better Care Reconciliation Act, S 1835, the Lower Premiums Through Reinsurance Act of 2017, and the Graham/Cassidy amendment to the American Health Care Act; HR 3120, a bill to amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; HR 3767 and S 989, the Ensuring Childrens Access to Specialty Care Act of 2017; HR 3635, the Local Coverage Determination Clarification Act of 2017; Ways and Means Committee Medicare extenders policy/legislation; above-mentioned issues included in HR 1892, the Bipartisan Budget Act of 2018.

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a demonstration project.

Client expense: $210,000 · Firm income: Not reported

114th Congress HR 605/S. 275 - Reintroduction of The Medicare Home Infusion Site of Care Act HR 3178, S. 1738, HR 3163, HR 1892 - lobbied House and Senate for temporary transitional home infusion clinical services reimbursement H.R.4724 - Medicare IVIG Access Enhancement Act, technical assistance

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.3163 - To amend title XVIII of the Social Security Act to provide for a home infusion therapy services temporary transitional payment under the Medicare program. H.R.3178 - Medicare Part B Improvement Act of 2017 S.1738 - Medicare Home Infusion Therapy Access Act of 2017

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3163 - To amend title XVIII of the Social Security Act to provide for a home infusion therapy services temporary transitional payment under the Medicare program. H.R.3178 - Medicare Part B Improvement Act of 2017 S.1738 - Medicare Home Infusion Therapy Access Act of 2017

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-Medicare coverage of home infusion drugs and biologics, including payment for durable medical equipment drugs and biologics. -21st Century Cures (P.L. 114-255): Sec. 5012 - Medicare Coverage of Home Infusion Therapy. -H.R. 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act -H.R. 3178 - Medicare Part B Improvement Act of 2017

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare Part D and Medicare payment for home infusion. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S. 1738/H.R. 3163, The Medicare Home Infusion Therapy Act of 2017 H.R. 3178, The Medicare Part B Improvement Act of 2017

Client expense: $1,680,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office

114th Congress HR 605/S. 275 - Reintroduction of The Medicare Home Infusion Site of Care Act HR 3178, S. 1738, HR 3163 - lobbied House and Senate for temporary transitional home infusion clinical services reimbursement HR 3178, HR 3172, HR 3823 - IVIG Coverage Demonstration - Lobbied House and Senate for extension of demonstration. H.R. 4229, lobbied in support of the Protecting Home Oxygen & Medical Equipment Access Act

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

-Medicare coverage of home infusion drugs and biologics, including payment for durable medical equipment drugs and biologics. -21st Century Cures (P.L. 114-255): Sec. 5012 - Medicare Coverage of Home Infusion Therapy. -H.R. 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act -H.R. 3178 - Medicare Part B Improvement Act of 2017

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.

Client expense: $120,000 · Firm income: Not reported

Medicare physician payment; new/alternative payment models; Medicare coverage; Medicare hospital payment; access to Medicare claims data; Ways & Means Committee hospital payment project; physician and hospital quality; electronic health record incentive program; clinical data registries; health care quality; medical imaging and prior authorization; the Stark Law and the in-office ancillary services exception including HR 4206/S 2051, the Medicare Care Coordination Improvement Act; Promoting Integrity in Medicare Act, HR 2066; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; HR 1155/S 1361, a bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs; S 46, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017; S 428, The Advancing Care for Exceptional Kids Act of 2017, a bill to allow a state, at its option, to elect to provide medical assistance for items and services furnished to eligible children with medically complex conditions enrolled in a Medicaid Children's Care Coordination (MCCC) program; Senate Finance Committee chronic care project; graduate medical education policy including HR 2267/S 1301, Resident Physician Shortage Reduction Act of 2017; end of life care, including HR 2797/S 1334, the Patient Choice and Quality Care Act of 2017; Children's Health Insurance Program (CHIP) extension, including HR 3922, the CHAMPIONING HEALTHY KIDS Act; Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) implementation; oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; repeal of the Independent Payment Advisory Board (IPAB), including S 251, the Protecting Medicare from Executive Action Act, S 260, the Protecting Seniors' Access to Medicare Act, SJ Res 16, SJ Res 17, and HR Res 51, joint resolutions approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Payment Advisory Board, and HR 849, a bill to repeal the IPAB; physician-owned hospital policy, including HR 1156/S 1133, the Patient Access to High Quality Care Act of 2017; Medicaid eligibility: HR 829, Prioritizing the Most Vulnerable Over Lottery Winners Act of 2017, HR 181, Close Annuity Loopholes in Medicaid Act, and HR 705, Verify Eligibility Coverage Act; HR 3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; Affordable Care Act repeal/replace/reform efforts, including the American Health Care Act, the Better Care Reconciliation Act, S 1835, the Lower Premiums Through Reinsurance Act of 2017, and the Graham/Cassidy amendment to the American Health Care Act; HR 3120, a bill to amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; HR 3767 and S 989, the Ensuring Childrens Access to Specialty Care Act of 2017; HR 3635, the Local Coverage Determination Clarification Act of 2017; Ways and Means Committee Medicare extenders policy/legislation.

H.R.3163 - To amend title XVIII of the Social Security Act to provide for a home infusion therapy services temporary transitional payment under the Medicare program. H.R.3178 - Medicare Part B Improvement Act of 2017 S.1738 - Medicare Home Infusion Therapy Access Act of 2017

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.

Client expense: $130,000 · Firm income: Not reported

Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act of 2017 S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S. 1738/H.R. 3163, The Medicare Home Infusion Therapy Act of 2017 H.R. 3178, The Medicare Part B Improvement Act of 2017 H.R. 3823, The Disaster Tax Relief and Airport and Airway Extension Act of 2017

Client expense: $1,450,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office

-Medicare coverage of home infusion drugs and biologics, including payment for durable medical equipment drugs and biologics. -H.R. 6 - 21st Century Cures (P.L. 114-255): Sec. 5012 - Medicare Coverage of Home Infusion Therapy. -H.R. 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act -H.R. 3178 - Medicare Part B Improvement Act of 2017

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

114th Congress HR 605/S. 275 - Reintroduction of The Medicare Home Infusion Site of Care Act HR 3178, S. 1738, HR 3163 - lobbied House and Senate for temporary transitional home infusion clinical services reimbursement HR 3178, HR 3172, HR 3823 - IVIG Coverage Demonstration - Lobbied House and Senate for extension of demonstration. Various Medicare red tape issues submitted to Ways and Means Committee in response to their call for red tape reduction ideas, no legislation introduced.

Client expense: $101,295 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Orphan drug tax exclusion in the Patient Protection and Affordable Care Act Legislation pertaining to orphan drugs H.R. 3163 (Medicare Part B Home Infusion Services Temporary Transitional Payment Act), all provisions

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office

Medicare physician payment; new/alternative payment models; Medicare coverage; Medicare hospital payment; access to Medicare claims data; Ways & Means Committee hospital payment project; physician and hospital quality; electronic health record incentive program; clinical data registries; health care quality; medical imaging and prior authorization; the Stark Law and the in-office ancillary services exception; Promoting Integrity in Medicare Act, HR 2066; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; HR 1155/S 1361, a bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs; S 46, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017; S 428, The Advancing Care for Exceptional Kids Act of 2017, a bill to allow a state, at its option, to elect to provide medical assistance for items and services furnished to eligible children with medically complex conditions enrolled in a Medicaid Children's Care Coordination (MCCC) program; Senate Finance Committee chronic care project; graduate medical education policy including HR 2267/S 1301, Resident Physician Shortage Reduction Act of 2017; end of life care, including HR 2797/S 1334, the Patient Choice and Quality Care Act of 2017; Children's Health Insurance Program (CHIP) extension; Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) implementation; oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; repeal of the Independent Payment Advisory Board (IPAB), including S 251, the Protecting Medicare from Executive Action Act, S 260, the Protecting Seniors' Access to Medicare Act, SJ Res 16, SJ Res 17, and HR Res 51, joint resolutions approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Payment Advisory Board, and HR 849, a bill to repeal the IPAB; physician-owned hospital policy, including HR 1156/S 1133, the Patient Access to High Quality Care Act of 2017; Medicaid eligibility: HR 829, Prioritizing the Most Vulnerable Over Lottery Winners Act of 2017, HR 181, Close Annuity Loopholes in Medicaid Act, and HR 705, Verify Eligibility Coverage Act; HR 3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; Affordable Care Act repeal/replace reform efforts, including the American Health Care Act, the Better Care Reconciliation Act and the Graham/Cassidy amendment to the American Health Care Act; HR 3120, a bill to amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; H.R. 3767 and S. 989, the Ensuring Childrens Access to Specialty Care Act of 2017; H.R. 3635, the Local Coverage Determination Clarification Act of 2017.

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.

Client expense: $50,000 · Firm income: Not reported

H.R.3163 - To amend title XVIII of the Social Security Act to provide for a home infusion therapy services temporary transitional payment under the Medicare program. H.R.3178 - Medicare Part B Improvement Act of 2017 S.1738 - Medicare Home Infusion Therapy Access Act of 2017

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare physician payment; new/alternative payment models; Medicare coverage; Medicare hospital payment; access to Medicare claims data; Ways & Means Committee hospital payment project; physician and hospital quality; electronic health record incentive program; clinical data registries; health care quality; medical imaging and prior authorization; the Stark Law and the in-office ancillary services exception; Promoting Integrity in Medicare Act, HR 2066; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; HR 1155, a bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs; S 46, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017; S 428, The Advancing Care for Exceptional Kids Act of 2017, a bill to allow a state, at its option, to elect to provide medical assistance for items and services furnished to eligible children with medically complex conditions enrolled in a Medicaid Children's Care Coordination (MCCC) program; Senate Finance Committee chronic care project; graduate medical education policy including HR 2267/S 1301, Resident Physician Shortage Reduction Act of 2017; end of life care, including HR 2797/S 1334, the Patient Choice and Quality Care Act of 2017; Children's Health Insurance Program (CHIP) extension; Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) implementation; oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; repeal of the Independent Payment Advisory Board (IPAB), including S 251, the Protecting Medicare from Executive Action Act, S 260, the Protecting Seniors' Access to Medicare Act, SJ Res 16, SJ Res 17, and HR Res 51, joint resolutions approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Payment Advisory Board, and HR 849, a bill to repeal the IPAB; physician-owned hospital policy, including HR 1156/S 1133, the Patient Access to High Quality Care Act of 2017; Medicaid eligibility: HR 829, Prioritizing the Most Vulnerable Over Lottery Winners Act of 2017, HR 181, Close Annuity Loopholes in Medicaid Act, and HR 705, Verify Eligibility Coverage Act; HR 3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; Affordable Care Act repeal/replace reform efforts, including the American Health Care Act and the Better Care Reconciliation Act.

-Medicare coverage of home infusion drugs and biologics, including payment for durable medical equipment drugs and biologics. -H.R. 6 - 21st Century Cures (P.L. 114-255): Sec. 5012 - Medicare Coverage of Home Infusion Therapy. -H.R. 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act -H.R. 3178 - Medicare Part B Improvement Act of 2017

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Non-specific policy related to home infusion and reimbursement. H.R. 224 - Consolidated Appropriations Act 2017 H.R. 3163 - To amend Title XVIII of the Social Security Act to provide home infusion therapy services temporary transitional payment under Medicare H.R. 3178 - Medicare Part B Improvement Act 2017

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Non-specific policy related to home infusion and reimbursement. H.R. 224 - Consolidated Appropriations Act 2017 H.R. 3163 - To amend Title XVIII of the Social Security Act to provide home infusion therapy services temporary transitional payment under Medicare H.R. 3178 - Medicare Part B Improvement Act 2017

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE